학술논문
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression
Document Type
TEXT
Author
Gluz, O.; Huober, J.; Kreipe, H. H.; Kates, R. E.; Hartmann, A.; Erber, R.; Scholz, M.; Lisboa, B.; Mohrmann, S.; Möbus, V.; Augustin, D.; Hoffmann, G.; Weiss, E.; Böhmer, S.; Kreienberg, R.; Du Bois, A.; Sattler, D.; Thomssen, C.; Kiechle, M.; Jänicke, F.; Wallwiener, D.; Harbeck, N.; Kuhn, W.; Nitz, U.
Source
Subject
Language
English
German
German